Suchergebnisse - "Mo, Hongnan"

PubPharm (59)

1

Impact of HER2-low expression on the efficacy of endocrine therapy with or without CDK4/6 inhibitor in HR-positive/HER2-negative metastatic breast cancer : A prospective study

enthalten in: Thoracic cancer | 2024

von Wu, Y. | Mo, H. | Xu, H. | +4

2

Safety and efficacy study of oral metronomic capecitabine combined with pyrotinib in HER2-positive metastatic breast cancer : A phase II trial

enthalten in: Breast (Edinburgh, Scotland) | 2023

von He, M. | Liu, J. | Wang, Z. | +11

3

MTA1, a Novel ATP Synthase Complex Modulator, Enhances Colon Cancer Liver Metastasis by Driving Mitochondrial Metabolism Reprogramming

enthalten in: Advanced science (Weinheim, Baden-Wurttemberg, Germany) | 2023

von Wang, T. | Sun, F. | Li, C. | +12

4

MTA1, a Novel ATP Synthase Complex Modulator, Enhances Colon Cancer Liver Metastasis by Driving Mitochondrial Metabolism Reprogramming

enthalten in: Advanced Science | 2023

von Wang, T. | Sun, F. | Li, C. | +12

5

Serum sodium ions and chloride ions associated with taxane-induced peripheral neuropathy in Chinese patients with early-stage breast cancer : A nation-wide multicenter study

enthalten in: Breast (Edinburgh, Scotland) | 2023

von Zhai, J. | Sun, X. | Zhao, F. | +8

6

Association of Taxane Type With Patient-Reported Chemotherapy-Induced Peripheral Neuropathy Among Patients With Breast Cancer

enthalten in: JAMA network open | 2022

von Mo, H. | Yan, X. | Zhao, F. | +11

7

S6K1 amplification confers innate resistance to CDK4/6 inhibitors through activating c-Myc pathway in patients with estrogen receptor-positive breast cancer

enthalten in: Molecular cancer | 2022

von Mo, H. | Liu, X. | Xue, Y. | +10

8

S6K1 amplification confers innate resistance to CDK4/6 inhibitors through activating c-Myc pathway in patients with estrogen receptor-positive breast cancer

enthalten in: Molecular cancer | 2022

von Mo, H. | Liu, X. | Xue, Y. | +10

9

S6K1 amplification confers innate resistance to CDK4/6 inhibitors through activating c-Myc pathway in patients with estrogen receptor-positive breast cancer

enthalten in: Molecular cancer | 2022

von Mo, H. | Liu, X. | Xue, Y. | +10

10

Novel model for accurately predicting curative effect of breast cancer immunotherapy and application thereof

enthalten in: Europäisches Patentamt | 2022

von MA FEI | QIAN HAILI | MO HONGNAN | +2

1
2
3
4
5
6
Nächster »
[6]